| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815876 | Neuropharmacology | 2012 | 12 Pages |
Abstract
⺠Treatment with MAM on GD17 models aspects of schizophrenia. ⺠NMDAR antagonists increase wakefulness, LMA, gamma and high freq oscillations. ⺠MAM animals have increased response only to the open channel NMDAR blockers. ⺠Reduced gamma oscillations in MAM animals correlate to reduce PV expression.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
K.G. Phillips, M.C. Cotel, A.P. McCarthy, D.M. Edgar, M. Tricklebank, M.J. O'Neill, M.W. Jones, K.A. Wafford,